Day TWO of #PROSCA25
#GlobalForum25 in Portugal 🇵🇹
Presentation by Eva Compérat during the Looking ahead: PCa management in 2026
Discussing the View of the Pathologist
Genetic testing has become a routine part of clinical practice, w/ biomarkers playing an increasingly important role
Day TWO of #PROSCA25
#GlobalForum25 in Portugal 🇵🇹
Presentation by Rob Jones 🇬🇧 during the Looking ahead: PCa management in 2026 Session
Discussing The View of the Oncologist
Day TWO of #PROSCA25
#GlobalForum25 in Portugal 🇵🇹
Thomas Zilli 🇨🇭 Presenting in the Looking ahead: PCa management in 2026 Session
Discussing View of the radiation oncologist☢️
The future of radiotherapy for #ProstateCancer is moving beyond a “one-size-fits-all” approach toward more personalized
Day TWO of #PROSCA25
#GlobalForum25 in Portugal 🇵🇹
Léa Turpin 🇫🇷 Presents Update lecture: The future of radioligands in PCa
PSMA PET/CT is rapidly becoming the new gold standard for imaging prostate cancer, offering superior detection and staging capabilities
Day TWO of #PROSCA25
#GlobalForum25 in Portugal 🇵🇹
Presenting Update lecture: Will AI replace the physician in PCa treatment?
Presentation by Badrinath Konety 🇺🇸
#ProstateCancer
Day TWO of #PROSCA25
#GlobalForum25 in Portugal 🇵🇹
Presentation by Aurelius Omlin 🇨🇭during the Case discussion session: CRPC
Presenting: Targeting CRPC with PARPi & immunotherapy
#ProstateCancer
Arthur, a 71-year-old patient experiencing symptomatic progression on ADT plus enzalutamide
Day TWO of #PROSCA25
#GlobalForum25 in Portugal 🇵🇹
Presentation by Bertrand Tombal 🇧🇪 during the Case discussion session: CRPC
Presenting: Combination approaches in first-line CRPC #ProstateCancer
Multiple major guidelines strongly endorse the use of bone-protecting agents (BPAs) i
Day ONE of #PROSCA25
#GlobalForum25 in Portugal 🇵🇹
Presentation by Bertrand Tombal 🇧🇪 during the Case discussion session: mHSPC Session
Discussing Treatment de-escalation in mHSPC
In metastatic hormone-sensitive #ProstateCancer , many patients achieve a deep PSA response w/ ADT + ARPI
Day ONE of #PROSCA25
#GlobalForum25 in Portugal 🇵🇹
Presentation by Vérane Achard 🇫🇷 during the Unfavourable intermediate- and high-risk PCa Session
Presenting : Optimising treatment in high-risk BCR patients
#ProstateCancer
Day ONE of #PROSCA25
#GlobalForum25 in Portugal 🇵🇹
Presentation by Julien Van Damme 🇧🇪 during the Unfavourable intermediate- and high-risk PCa Session
Presenting: PSA-only monitoring in BCR
PSA-only biochemical recurrence represents a highly heterogeneous disease state
#ProstateCancer
Day ONE of #PROSCA25
#GlobalForum25 in Portugal 🇵🇹
Presentation by Bertrand Tombal 🇧🇪 during the Unfavourable intermediate- and high-risk PCa Session
Presenting: Treatment strategies for elderly with locally advanced #ProstateCancer
It has been an incredible few days at #RENALC25 and #BLADDR25, with a combined 4.3 million impressions—and the numbers continue to rise. Today, we launch the oldest and largest meeting of the series: #GLOBALFORUM25 / #PROSCA25!
In about 30 minutes we KICK off the #GlobalForum25 with #RENALC25 , #BLADDR25 and ending with #PROSCA25 discussing the latest in #KidneyCancer #BladderCancer and #ProstateCancer with an amazing internationa faculty!
